Documents

2013-14 SPIL- Annual Report

Description
Annual report. sunpharma
Categories
Published
of 144
All materials on our website are shared by users. If you have any questions about copyright issues, please report us to resolve them. We are always happy to assist you.
Related Documents
Share
Transcript
  GROWTH IS A CONSTANT 13 14 SUN PHARMACEUTICAL INDUSTRIES LTD.ANNUAL REPORT  02 Key Performance Indicators 03 Ten Year Financial Highlights 04 Management Discussion and Analysis Report 30 Directors’ Report 36 Corporate Governance 54 Standalone Financial Statements 100 Consolidated Financial Statements CONTENTS  ANNUAL REPORT 2013-14 In a dynamic industry landscape, our overall    unwavering focus on consistent growth. Despite a constantly changing operating environment, we have been able to accelerate growth. FY14 was no exception to this. During the year, we not only retained our momentum, but enhanced it, despite a changing regulatory and operating landscape. GROWTH IS A CONSTANT At Sun Pharma, our corporate strategy is geared towards embracing emerging opportunities, delivering a consistent performance and ensuring the health and wellness of patients. The corporate structure is    changes to support our enhanced scale of operations and an expanding global presence. However, even as the internal and external environment keeps changing, our focus on growth remains steadfast.The result is a constantly accelerating performance and a stronger commitment to reach new frontiers in our business.  2 SUN PHARMACEUTICAL INDUSTRIES LTD. KEY PERFORMANCE INDICATORS R&D Expenditure ( `  million)04-05 05-06 06-07 07-08 08-09 09-10 10-11 11-12 12-13 13-14 10,4187,0424,4493,3132,4693,3202,8592,7872,0151,427 Net Block  ( `  million)04-05 05-06 06-07 07-08 08-09 09-10 10-11 11-12 12-13 13-14 49,82745,14529,29525,21415,32814,62510,3549,5148,5635,719 Earning Per Share - Basic* ( ` )04-05 05-06 06-07 07-08 08-09 09-10 10-11 11-12 12-13 13-14 15.228.825.717.565.287.874.741.730.921.3 Reserve & Surplus ( `  million)04-05 05-06 06-07 07-08 08-09 09-10 10-11 11-12 12-13 13-14 183,178148,862121,32293,79877,25469,41448,87926,74714,95910,366 Total Income ( `  million)04-05 05-06 06-07 07-08 08-09 09-10 10-11 11-12 12-13 13-14 166,326116,88084,91060,82742,12344,80835,01723,74518,04212,301 Net Proft ( `  million)04-05 05-06 06-07 07-08 08-09 09-10 10-11 11-12 12-13 13-14 31,41429,83126,56718,16113,47018,78015,5098,4025,7304,002 * During the nancial year 2004-05, the company issued bonus shares in the ratio of one equity share of `  5/- for every share held. * During the nancial year 2010-11, each Equity share of `  5/- was split into ve equity shares of `  1/- each. * During the nancial year 2013-14, the company issued bonus shares in the ratio of one equity share of `  1/- for every share held.

mod04

Jul 22, 2017

space.pdf

Jul 22, 2017
We Need Your Support
Thank you for visiting our website and your interest in our free products and services. We are nonprofit website to share and download documents. To the running of this website, we need your help to support us.

Thanks to everyone for your continued support.

No, Thanks
SAVE OUR EARTH

We need your sign to support Project to invent "SMART AND CONTROLLABLE REFLECTIVE BALLOONS" to cover the Sun and Save Our Earth.

More details...

Sign Now!

We are very appreciated for your Prompt Action!

x